Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Figarola: Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90.... (0.08 sec) 

Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in …


JL Figarola, N Shanmugam, R Natarajan, S Rahbar - Diabetes, 2007 - Am Diabetes Assoc
Ligation of advanced glycation end products (AGEs) with their receptor (RAGE) plays an important
role in the development of various diabetes complications, including atherosclerosis. Monocyte
activation, adhesion, and migration are key events in the pathogenesis of atherosclerosis. ...
Cited by 29 - Related articles - BL Direct - All 6 versions

LR-90 a new advanced glycation endproduct inhibitor prevents progression of …


JL Figarola, S Scott, S Loera, C Tessler, P Chu, L … - Diabetologia, 2003 - Springer
Aims/hypothesis. Advanced glycation and lipoxidation endproducts have been implicated in
the pathogenesis of diabetic complications, including diabetic nephrop- athy. LR-90, a new advanced
glycation endproduct in- hibitor, was investigated for its effects on the develop- ment of ...
Cited by 54 - Related articles - BL Direct - All 3 versions

Novel inhibitors of glycation and AGE formation


S Rahbar - Cell biochemistry and biophysics, 2007 - Springer
Abstract Accelerated formation of advanced glycation/ lipoxidation and endproducts
(AGEs/ALEs) has been implicated in the pathogenesis of various diabetic com- plications. Several
natural and synthetic compounds have been proposed and tested as inhibitors of ...
Cited by 10 - Related articles - BL Direct - All 5 versions

Prevention of early renal disease, dyslipidaemia and lipid peroxidation in STZ- …


JL Figarola, S Scott, S Loera, B Xi, T Synold, L … - Diabetes/Metabolism … - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 7 - Related articles - BL Direct - All 3 versions

Pyridoxal-aminoguanidine adduct is more effective than aminoguanidine in …


AS Chen, T Taguchi, M Sugiura, Y … - Hormone and …, 2004 - thieme-connect.com
We examined the ability of a pyridoxal-aminoguanidine adduct with both antiglycation and antioxidant
activities in vitro to protect against neuropathy and cataract in streptozotocin-diabetic rats and
compared the result with that of aminoguanidine. In vivo antiglycation and antioxidant ...
Cited by 16 - Related articles - BL Direct - All 4 versions

[CITATION] Hyperglycemia and insulin resistance: possible mechanism. NY Acad Sci. 2002; …


E Thomas, YS Lin, Z Dagher… - Links
Cited by 2 - Related articles

[CITATION] The pathobiology of diabetic complications-a unifying mechanism. diabetes. 2005; …


M Brownle - Links
Cited by 2 - Related articles

Functional interaction between the glucocorticoid receptor and GANP/MCM3AP


W Osman, S Laine, J Zilliacus - Biochemical and Biophysical Research …, 2006 - Elsevier
Glucocorticoids are widely used to treat inflammatory diseases but have a number of side effects
that partly are connected to inhibition of cell proliferation. Glucocorticoids mediated their action
by binding to the glucocorticoid receptor. In the present study, we have identified by two- ...
Cited by 2 - Related articles - All 5 versions

[CITATION] The biochemical and cellular basis of cell proliferation assays that use terazolium …


M Berridge, R Wang - Links
Cited by 2 - Related articles

[CITATION] Zucker diabetic fatty as a model for non-insulin dependent diabetes mellitus


PRGS WN, MA Neel… - ILAR News, 1990
Cited by 2 - Related articles


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google